Isaac Ciechanover has left US-based biotech company Celgene Corporation after running its in-house venture capital division in order to join top tier independent VC Kleiner Perkins Caufield & Byers.
Isaac Ciechanover has left US-based biotech company Celgene Corporation after running its in-house venture capital division in order to join top tier independent VC Kleiner Perkins Caufield & Byers.
Silicon Valley-based Kleiner Perkins Caufield & Byers effectively helped found the biotech industry by forming Genentech, which has since been in the process of full acquisition by pharmaceutical giant Roche, and Ciechanover will be a partner in its life sciences team. He will provide counsel and guidance to the firm’s network of…
